To evaluate whether helmet noninvasive ventilation compared to usual respiratory support reduces 180-day mortality and improves health-related quality of life (HRQoL) in patients with acute hypoxemic respiratory failure due to COVID-19 pneumonia. Methods: This is a pre-planned follow-up study of the Helmet-COVID trial. In this multicenter, randomized clinical trial, adults with acute hypoxemic respiratory failure (n = 320) due to coronavirus disease 2019 (COVID-19) were randomized to receive helmet noninvasive ventilation or usual respiratory support.
Long-term outcomes of patients with COVID-19 treated with helmet noninvasive ventilation or usual respiratory support: follow-up study of the Helmet-COVID randomized clinical trial / Arabi Y.M.; Al-Dorzi H.M.; Aldekhyl S.; Al Qahtani S.; Abdukahil S.A.; Al Qasim E.; Al Harbi M.K.; Kharaba A.; Albrahim T.; Alshahrani M.S.; Al-Fares A.A.; Al Bshabshe A.; Mady A.; Al Duhailib Z.; Algethamy H.; Jose J.; Al Mutairi M.; Al Zumai O.; Al Haji H.; Alaqeily A.; Al Wehaibi W.; Al Aseri Z.; Al-Omari A.; Tlayjeh H.; Al-Dawood A.; Al-Qahtani S.; Al-Harbi M.K.; Al-Mutairi M.; Al-Haji H.; Al-Zumai O.; Al-Qasim E.; Al-Dorzi H.; Hill N.; Nava S.; Mojica J.; Harhay M.; Al-Fares A.; Almumin A.; Albert J.; Khan I.; Ayaz M.; Al Bshabshe A.; Aldammad M.M.; Alwadai N.M.; Palanivel O.P.; Al Harbi M.; Al Qahtani S.; Abdukahil S.A.I.; Sadat M.; Afesh L.; Bin Humaid F.; Al Mutairi M.; Ismaiel Y.; Al Baseet F.; Al Obaidi M.; Tabhan E.; Al Khalid R.; Al Fares O.; Al Suayb A.; Sammanoudi H.; Burrows V.; Matroud A.; Naidu B.; Lungue S.; Khan L.; Jaber M.; Baaziz S.; Nuzhat S.; Albrahim T.A.; Asonto L.P.; Mapusao C.; Muthu A.; AlGhamdi A.S.; Angala C.; Hussien M.; AlFar A.; Al Asiri S.; Al Solami A.; Abu Riash M.; Al Othaimeen H.; Huma R.; Aldosari N.A.; Alreyes K.A.; Lakshmanan A.P.; Al Obaed A.; Almushhen M.; Hali F.; Fibriantini I.; Marasigan B.R.; Baguisa K.; Almahwi S.A.; Chalabi J.; Al-Hameed F.; Bin Eshaq A.; Alqahtani R.; Alnafel O.. - In: INTENSIVE CARE MEDICINE. - ISSN 0342-4642. - STAMPA. - 49:3(2023), pp. 302-312. [10.1007/s00134-023-06981-5]
Long-term outcomes of patients with COVID-19 treated with helmet noninvasive ventilation or usual respiratory support: follow-up study of the Helmet-COVID randomized clinical trial
Nava S.;
2023
Abstract
To evaluate whether helmet noninvasive ventilation compared to usual respiratory support reduces 180-day mortality and improves health-related quality of life (HRQoL) in patients with acute hypoxemic respiratory failure due to COVID-19 pneumonia. Methods: This is a pre-planned follow-up study of the Helmet-COVID trial. In this multicenter, randomized clinical trial, adults with acute hypoxemic respiratory failure (n = 320) due to coronavirus disease 2019 (COVID-19) were randomized to receive helmet noninvasive ventilation or usual respiratory support.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
